Gemtuzumab Ozogamicin (GO) for Acute Myeloid Leukaemia (AML)

What's in this booklet? 

Gemtuzumab Ozogamicin (GO) is a drug specifically developed for the treatment of acute myeloid leukaemia. It combines a man-made antibody to leukaemia cells and a chemotherapy drug which kills living cells. 

This hardcopy version of our booklet can be ordered free of charge to UK addresses. 

Digital downloads

To access an instant download of our Gemtuzumab Ozogamicin (GO) for Acute myeloid leukaemia information booklet, please click here (opens as a PDF file). 

All our information is available free of charge to people affected by leukaemia and associated conditions. It costs us approximately £3 to provide one booklet. Please consider adding a donation to your order if you can.